EPKINLY Trademark

Trademark Overview

On Monday, December 6, 2021, a trademark application was filed for EPKINLY with the United States Patent and Trademark Office. The USPTO has given the EPKINLY trademark a serial number of 97157220. The federal status of this trademark filing is REGISTERED as of Tuesday, August 8, 2023. This trademark is owned by AbbVie Biotechnology Ltd. The EPKINLY trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders
epkinly

General Information

Serial Number97157220
Word MarkEPKINLY
Filing DateMonday, December 6, 2021
Status700 - REGISTERED
Status DateTuesday, August 8, 2023
Registration Number7134382
Registration DateTuesday, August 8, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 2, 2022

Trademark Statements

Goods and Servicespharmaceutical preparations and substances for the treatment of oncological related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 10, 2021
Primary Code005
First Use Anywhere DateFriday, May 19, 2023
First Use In Commerce DateFriday, May 19, 2023

Trademark Owner History

Party NameGENMAB A/S
Party Type31 - New Owner After Registration
Legal Entity Type65 - NOT AVAILABLE
AddressVALBY 2500
DK
Party NameAbbVie Biotechnology Ltd
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHamilton HM11
BM
Party NameAbbVie Biotechnology Ltd
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHamilton HM11
BM
Party NameAbbVie Biotechnology Ltd
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHamilton HM11
BM

Trademark Events

Event DateEvent Description
Thursday, December 9, 2021NEW APPLICATION ENTERED
Friday, December 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 27, 2022ASSIGNED TO EXAMINER
Monday, June 27, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 13, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 2, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 2, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, March 23, 2023SOU TEAS EXTENSION RECEIVED
Thursday, March 23, 2023SOU EXTENSION 1 FILED
Thursday, March 23, 2023SOU EXTENSION 1 GRANTED
Saturday, March 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 30, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, May 30, 2023USE AMENDMENT FILED
Thursday, June 22, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 22, 2023STATEMENT OF USE PROCESSING COMPLETE
Saturday, July 1, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 4, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 8, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, August 8, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, April 3, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, May 8, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 8, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 8, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, May 8, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 8, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 8, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, May 8, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Related Keywords

epkinly related diseases disorders oncological treatment preparations substances pharmaceutical